We are live on
!
Find out more
GT
Greenleaf Trust Portfolio holdings
AUM
$10.4B
1-Year Est. Return
0.97%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+0.97%
3 Year Est. Return
+37.24%
5 Year Est. Return
+56.69%
10 Year Est. Return
+246.06%
AUM
$3.15B
AUM Growth
+$40.3M
(+1.3%)
Cap. Flow
-$80.6M
Cap. Flow
% of AUM
-2.56%
Top 10 Holdings %
Top 10 Hldgs %
85.39%
Holding
170
New
12
Increased
40
Reduced
76
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$16.2M |
| 2 |
Bankunited
BKU
|
+$12.7M |
| 3 |
Cinemark Holdings
CNK
|
+$6.51M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.97M |
| 5 |
NetApp
NTAP
|
+$1.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$34M |
| 2 |
SHPG
Shire pic
SHPG
|
+$21.1M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$18.3M |
| 4 |
NextEra Energy
NEE
|
+$9.46M |
| 5 |
Apple
AAPL
|
+$7.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.7% |
| 2 | Technology | 3.76% |
| 3 | Financials | 3.32% |
| 4 | Communication Services | 1.59% |
| 5 | Energy | 1.47% |
Similar funds
WAM
OIA
PF
VPIM
ACA
IIM
CG
GI
Greenleaf Trust's Q2 2014 Portfolio in Review
As of Q2 2014, Greenleaf Trust held 170 positions worth $3.15B, up 1.3% from $3.11B the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Greenleaf Trust's Q2 2014 filing shows 12 new, 40 increased, 76 reduced and 8 closed positions. Its largest new stake was Express Scripts Holding Company: 229,873 shares worth $15.9M. The largest sale was Stryker, an estimated $34M.
By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 80% a quarter earlier, followed by Technology and Financials.
- Greenleaf Trust's largest Q2 2014 buy was Express Scripts Holding Company: 229,873 shares worth $15.9M.
- Greenleaf Trust added most to iShares Core S&P 500 ETF in Q2 2014, an estimated $1.97M increase.
- Greenleaf Trust's biggest Q2 2014 reduction was Stryker, cutting an estimated $34M.
- Greenleaf Trust fully exited Bristol-Myers Squibb in Q2 2014, selling an estimated $750K.
- Greenleaf Trust's ten largest holdings make up 85% of its $3.15B portfolio in Q2 2014.
- Greenleaf Trust opened 12 new positions and closed 8 in Q2 2014.
- Greenleaf Trust's portfolio value rose 1.3% quarter-over-quarter to $3.15B.
Based on Greenleaf Trust's 13F filing for Q2 2014, filed 12 Aug 2014.